Drug-target residence time and its implications for lead optimization
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromolecules by low-molecular-mass drugs. The binding of drugs to their macromolecular targets is therefore seen as paramount for pharmacological activity. In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC(50) or K(d). This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex. We describe the potential advantages of long residence time in terms of duration of pharmacological effect and target selectivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translation between slow inhibitor binding kinetics and sustained pharmacodynamic modulation has been studied for a numberoftarget classes (58).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [58]
In the citing paper
“Furthermore, the targets of infectious diseases usually have high replication rates, while covalent inhibitors tend to have long residence times making them less effective in this area [128].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [128]
In the citing paper
“Furthermore, longer residence times of drugs with their targets, as a result of slower off-rates, is a useful mechanism to extend in-vivo efficacy (59–61).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [59]
Citations
Cites
Catalysis in chemistry and enzymology
Jencks, W. P. (1969) · Medical Entomology and Zoology · Cited by 3,217
Structure and Mechanism in Protein Science
Fersht, A. (1998) · Cited by 1,882
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Wood, E. R., Truesdale, A. T., McDonald, O. B., Yuan, D., Hassell, A., Dickerson, S. H., Ellis, B., Pennisi, C., Horne, E., Lackey, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1168 · Cited by 1,122
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Self-citationLiang, J., Woodward, C., & Edelsbrunner, H. (1998) · Protein Science · doi:10.1002/pro.5560070905 · Cited by 1,057
Enzymes: a practical introduction to structure, mechanism, and data analysis
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3881 · Cited by 1,056
Optical biosensors in drug discovery
Cooper, M. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd838 · Cited by 1,015
Oppenheimer, N. J., & James, T. L. (1989) · Academic Press eBooks · Cited by 820
Rusnak, D. W., Lackey, K. E., Affleck, K., Wood, E. R., Alligood, K. J., Rhodes, N., Keith, B. R., Murray, D. M., Knight, W. B., Mullin, R. J., et al. (2001) · PubMed · Cited by 728
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis
Copeland, R. A. (2000) · Wiley eBooks · doi:10.1002/0471220639 · Cited by 726
Self-citation
Cited by
Items 701–800 of 1,003
Insight into Thermodynamic and Kinetic Profiles in Small-Molecule Optimization
Liu, W., Jiang, J., Lin, Y., You, Q., & Wang, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00682 · Cited by 22
Structure–Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors
Basak, S., Li, Y., Tao, S., Daryaee, F., Merino, J., Gu, C., Delker, S. L., Phan, J. N., Edwards, T. E., Walker, S. G., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00974 · Cited by 20
Kinetic binding assays for the analysis of protein–ligand interactions
Meyer‐Almes, F. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.08.004 · Cited by 20
The different kinetic behavior of two potential photosensitizers for PDT
Barbero, N., Visentin, S., & Viscardi, G. (2014) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2014.11.002 · Cited by 20
Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor
Nederpelt, I., Bleeker, D. C. T., Tuijt, B., IJzerman, A. P., & Heitman, L. H. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.004 · Cited by 19
Vlot, A. H. C., de Witte, W. E. A., Danhof, M., van der Graaf, P. H., van Westen, G. J. P., & de Lange, E. C. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0172-7 · Cited by 20
Revisiting the Pharmacodynamic Uroselectivity of α1-Adrenergic Receptor Antagonists
Quaresma, B. M. C. S., Pimenta, A. R., da Silva, A. C. S., Pupo, A. S., Romeiro, L. A. S., Silva, C. L. M., & Noël, F. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.260216 · Cited by 20
Georgi, V., Dubrovskiy, A., Steigele, S., & Fernández‐Montalván, A. E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14841 · Cited by 20
Design and Discovery of Covalent α-GalCer Derivatives as Potent CD1d Ligands
Kishi, J., Inuki, S., Kashiwabara, E., Suzuki, T., Dohmae, N., & Fujimoto, Y. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00700 · Cited by 20
Elgawish, M. S., Nafie, M. S., Yassen, A. S. A., Yamada, K., & Ghareb, N. (2022) · New Journal of Chemistry · doi:10.1039/d1nj05655g · Cited by 21
Antagonist-radioligand binding to D2L-receptors in intact cells
Packeu, A., Backer, J. D., Liefde, I. V., Vanderheyden, P., & Vauquelin, G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.001 · Cited by 20
Neumann, L., Ritscher, A., Müller, G., & Hafenbradl, D. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9288-x · Cited by 20
Characterization of DNA-Conjugated Compounds Using a Regenerable Chip
Lin, W., Reddavide, F. V., Uzunova, V. P., Gür, F. N., & Zhang, Y. (2014) · Analytical Chemistry · doi:10.1021/ac503960z · Cited by 20
[3H]-F13640, a novel, selective and high-efficacy serotonin 5-HT1A receptor agonist radioligand
Heusler, P., Palmier, C., Tardif, S., Bernois, S., Colpaert, F. C., & Cussac, D. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0551-4 · Cited by 20
Biased GPCR Signaling: Possible Mechanisms and Therapeutic Applications
Fan, L., & Wang, S. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00827 · Cited by 21
Bisignano, P., Doerr, S., Harvey, M. J., Favia, A. D., Cavalli, A., & Fabritiis, G. D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci4006063 · Cited by 24
Ojha, A. A., Votapka, L. W., & Amaro, R. E. (2023) · Chemical Science · doi:10.1039/d3sc04195f · Cited by 19
Mustali, J., Yasuda, I., Hirano, Y., Yasuoka, K., Gautieri, A., & Arai, N. (2023) · RSC Advances · doi:10.1039/d3ra06375e · Cited by 22
Sykes, D. A., Dowling, M. R., & Charlton, S. J. (2010) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0914s50 · Cited by 19
Doyle, P. J., Saeed, H., Hermans, A., Gleddie, S., Hussack, G., Arbabi‐Ghahroudi, M., Seguin, C., Savard, M. E., MacKenzie, C. R., & Hall, J. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045047 · Cited by 22
Kingsley, L. J., & Lill, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099408 · Cited by 21
Potential Strategies for Increasing Drug-Discovery Productivity
Cumming, J. G., Finlay, M. R. V., Giordanetto, F., Hemmerling, M., Lister, T., Sanganee, H. J., & Waring, M. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.7 · Cited by 20
Kitagawa, D., Gouda, M., & Kirii, Y. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113506051 · Cited by 19
Zhang, R., & Wong, K. K. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1245721 · Cited by 20
Structure–Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D2 Receptor
Fyfe, T. J., Kellam, B., Sykes, D. A., Capuano, B., Scammells, P. J., Lane, J. R., Charlton, S. J., & Mistry, S. N. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00864 · Cited by 23
Salmaso, V., & Jacobson, K. A. (2020) · Biomolecules · doi:10.3390/biom10060812 · Cited by 20
Carling, C., & Brűlls, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.120116 · Cited by 19
Russi, M., Cavalieri, G., Marson, D., Laurini, E., & Pricl, S. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00100 · Cited by 19
Link, R., Veikšina, S., Rinken, A., & Kopanchuk, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.040 · Cited by 19
Milite, C., Barresi, E., Pozzo, E. D., Costa, B., Viviano, M., Porta, A., Messere, A., Sbardella, G., Settimo, F. D., Novellino, E., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01031 · Cited by 19
Alenazi, Y., Singh, K., Davies, G., Eaton, J. R. O., Elders, P. N. D., Kawamura, A., & Bhattacharya, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-24568-9 · Cited by 19
Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?
Raouf, Y. S., & Moreno–Yruela, C. (2024) · JACS Au · doi:10.1021/jacsau.4c00828 · Cited by 21
Methods for kinetic evaluation of reversible covalent inhibitors from time-dependent IC 50 data
Mader, L. K., & Keillor, J. W. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00050e · Cited by 20
Spiriti, J. M., & Wong, C. F. (2021) · Life · doi:10.3390/life11020074 · Cited by 18
Nie, W., Lu, Y., Pan, C., Gao, J., Luo, M., Du, J., Wang, J., Luo, P., Zhu, H., Che, J., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105673 · Cited by 18
Ren, T., Zhu, X., Jusko, N. M., Krzyżański, W., & Jusko, W. J. (2022) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-022-09822-y · Cited by 18
Guzzetti, S., & Gutierrez, P. M. (2023) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09857-9 · Cited by 20
Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era
Kappel, A. D., Jha, R., Guggilapu, S., Smith, W. J. B., Feroze, A. H., Dmytriw, A. A., Vicenty‐Padilla, J. C., Guardia, R. E. A., Gessler, F. A., Patel, N. J., et al. (2024) · Cancers · doi:10.3390/cancers16081594 · Cited by 18
Computational chemistry approaches to drug discovery in signal transduction
Fischer, P. M. (2008) · Biotechnology Journal · doi:10.1002/biot.200700259 · Cited by 23
Lin, J. C., Ettinger, R. A., Schuman, J. T., Zhang, A.-H., Wamiq-Adhami, M., Nguyen, P.-C., Nakaya-Fletcher, S. M., Puranik, K., Thompson, A. R., & Pratt, K. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116577 · Cited by 18
Li, H., Ge, J., Guo, T., Yang, S., He, Z., York, P., Sun, L., Xu, X., & Zhang, J. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.07.010 · Cited by 18
Alvarenga, M. L., Kikhney, J., Hannewald, J., Metzger, A. U., Steffens, K. ‐., Bomke, J., Krah, A., & Wegener, A. A. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.10.039 · Cited by 19
Swinney, Z., Haubrich, B. A., Xia, S., Ramesha, C. S., Gomez, S. R., Guyett, P. J., Mensa‐Wilmot, K., & Swinney, D. C. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004506 · Cited by 20
A binding kinetics study of human adenosine A3 receptor agonists
Xia, L., Kyrizaki, A., Tosh, D. K., van Duijl, T. T., Roorda, J. C., Jacobson, K. A., IJzerman, A. P., & Heitman, L. H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.026 · Cited by 18
Poganik, J. R., Long, M. J. C., & Aye, Y. (2018) · BioEssays · doi:10.1002/bies.201700240 · Cited by 21
Petrov, K. A., Nikolsky, E. E., & Masson, P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00766 · Cited by 18
Virtual screening in drug discovery: a precious tool for a still-demanding challenge
Rizzuti, B., & Grande, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819132-3.00014-2 · Cited by 23
Stuckey, J. I., Cantone, N. R., Côté, A., Arora, S., Vivat, V., Ramakrishnan, A., Mertz, J. A., Khanna, A., Brenneman, J. B., Gehling, V. S., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100349 · Cited by 18
Kinetic mechanisms of covalent inhibition
McWhirter, C. L. (2021) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.11.001 · Cited by 29
Bairy, S. G., & Wong, C. F. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.23072 · Cited by 18
Cheng, A., & Tsai, I. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.08.019 · Cited by 18
Allikalt, A., Kopanchuk, S., & Rinken, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.09.008 · Cited by 18
Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance–Based Fragment Screening
Aretz, J., & Rademacher, C. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00215 · Cited by 18
Stereoselective recognition of morphine enantiomers by μ -opioid receptor
Wang, Y., Ngo, V. A., & Wang, X. (2024) · National Science Review · doi:10.1093/nsr/nwae029 · Cited by 21
Deng, H., Wang, C., & Ye, F. (2013) · RSC Advances · doi:10.1039/c3ra40426a · Cited by 17
Bondza, S., Stenberg, J., Nestor, M., Andersson, K., & Björkelund, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500379d · Cited by 17
Meyer‐Almes, F. (2015) · European Biophysics Journal · doi:10.1007/s00249-015-1090-1 · Cited by 17
Principles for Tuning Hydrophobic Ligand–Receptor Binding Kinetics
Weiß, R. G., Setny, P., & Dzubiella, J. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00216 · Cited by 17
Magarkar, A., Schnapp, G., Apel, A.-K., Seeliger, D., & Tautermann, C. S. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00590 · Cited by 17
A Potent Mimetic of the Siglec‐8 Ligand 6’‐Sulfo‐Sialyl Lewisx
Kroezen, B. S., Conti, G., Girardi, B., Cramer, J., Jiang, X., Rabbani, S., Müller, J., Kokot, M., Luisoni, E., Ricklin, D., et al. (2020) · ChemMedChem · doi:10.1002/cmdc.202000417 · Cited by 17
Lamba, D., & Pesaresi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095072 · Cited by 17
Gu, X., Yuan, H., Zhao, W., Sun, N., Yan, W., Jiang, C., He, Y., Liu, H., Cheng, J., & Guo, D. M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01625 · Cited by 18
Slow Dissociation from the PARP1–HPF1 Complex Drives Inhibitor Potency
Stojanovic, P., Luger, K., & Rudolph, J. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00243 · Cited by 17
Martinez, C., Lagartera, L., Trujillo, C., & Dardonville, C. Y. (2015) · MedChemComm · doi:10.1039/c5md00292c · Cited by 17
Shapiro, A. B., Gao, N., Gu, R.-F., & Thresher, J. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.06.004 · Cited by 17
Fabini, E., Tramarin, A., & Bartolini, M. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.03.060 · Cited by 17
Wainberg, M. A. (2012) · Scientifica · doi:10.6064/2012/238278 · Cited by 18
Recognition Dynamics of p53 and MDM2: Implications for Peptide Design
ElSawy, K. M., Lane, D. P., Verma, C. S., & Caves, L. S. D. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b11162 · Cited by 18
Roles of Accelerated Molecular Dynamics Simulations in Predictions of Binding Kinetic Parameters
Chen, J., Wang, W., Sun, H., & He, W. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575252165231122095555 · Cited by 17
Kinetic and thermodynamic properties of MAG antagonists
Mesch, S., Lemme, K., Koliwer‐Brandl, H., Strasser, D. S., Schwardt, O., Kelm, S., & Ernst, B. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.03.010 · Cited by 16
Vendel, E., Rottschäfer, V., & de Lange, E. C. M. (2018) · Bulletin of Mathematical Biology · doi:10.1007/s11538-018-0469-4 · Cited by 17
Plescia, J., Cesco, S. D., Patrascu, M. B., Kurian, J., Trani, J. M. D., Dufresne, C., Wahba, A. S., Janmamode, N., Mittermaier, A., & Moitessier, N. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00642 · Cited by 16
The role of NMR in leveraging dynamics and entropy in drug design
Dubey, A., Takeuchi, K., Reibarkh, M., & Arthanari, H. (2020) · Journal of Biomolecular NMR · doi:10.1007/s10858-020-00335-9 · Cited by 17
A snake toxin as a theranostic agent for the type 2 vasopressin receptor
Droctové, L., Lancien, M., Tran, V. L., Susset, M., Jégo, B., Théodoro, F., Kessler, P., Mourier, G., Robin, P., Diarra, S. S., et al. (2020) · Theranostics · doi:10.7150/thno.47485 · Cited by 17
Wang, X., Phan, M. M., Sun, Y., Koerber, J. T., Ho, H., Chen, Y., & Yang, J. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114635 · Cited by 16
Zhang, Z., Lv, J., Wang, Y., Yu, H., Guo, B., Zhai, J., Wang, C., Zhao, Y., Fan, F., & Luo, W. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202203363 · Cited by 16
Merget, B., & Sotriffer, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127009 · Cited by 16
Detecting ligand interactions with G protein-coupled receptors in real-time on living cells
Xu, B., Varasteh, Z., Orlova, A., Andersson, K., Larhammar, D., & Björkelund, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.149 · Cited by 16
Molecular Dynamics Simulations of G Protein‐Coupled Receptors
Bruno, A., & Costantino, G. (2012) · Molecular Informatics · doi:10.1002/minf.201100138 · Cited by 18
Tian, G., Paschetto, K. A., Gharahdaghi, F., Gordon, E., Wilkins, D. E., Luo, X., & Scott, C. W. (2011) · Biochemistry · doi:10.1021/bi200552p · Cited by 19
Kinetics, Thermodynamics, and Ligand Efficiency Metrics in Drug Discovery
Holdgate, G. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12318-2 · Cited by 23
Rowedder, J. E., Ludbrook, S. B., & Slack, R. J. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217703908 · Cited by 16
Ramos, I., Aparici, M., Letosa, M., Puig, C., Gavaldà, A., Huerta, J. M., Espinosa, S., Vilella, D., & Miralpeix, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.043 · Cited by 16
Reiner‐Link, D., & Stark, H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.041 · Cited by 16
Discovery and characterization of a small‐molecule enteropeptidase inhibitor, SCO ‐792
Sasaki, M., Miyahisa, I., Itono, S., Yashiro, H., Hiyoshi, H., Tsuchimori, K., Hamagami, K., Moritoh, Y., Watanabe, M., Tohyama, K., et al. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.517 · Cited by 16
An Appraisal of Computer Simulation Approaches in Elucidating Biomolecular Recognition Pathways
Ahalawat, N., & Mondal, J. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02785 · Cited by 17
Drug–Target Interaction Kinetics: Underutilized in Drug Optimization?
Copeland, R. A. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0183 · Cited by 16
Self-citationChen, X., Huang, X., Ma, Q., Kuzmič, P., Zhou, B., Xu, J., Liu, B., Jiang, H., Zhang, W., Yang, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.09.531862 · Cited by 21
Yang, H., Li, X., Li, G., Huang, H., Yang, W., Jiang, X., Sen, M., Liu, J., Li, X., Pan, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111664 · Cited by 15
Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance
Gabrielsson, J., & Hjorth, S. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000524 · Cited by 18
Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors
Crawford, M. C., Tripu, D. R., Barritt, S. A., Jing, Y., Gallimore, D., Kales, S. C., Bhanu, N. V., Xiong, Y., Fang, Y., Butler, K. A. T., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00293 · Cited by 18
Truong, D. T., Ho, K., Pham, D. Q. H., Chwastyk, M., Nguyen-Minh, T., & Nguyen, M. T. (2024) · Scientific Reports · doi:10.1038/s41598-024-59899-3 · Cited by 15
Positive allosteric modulation of a GPCR ternary complex
Burger, W. A. C., Draper-Joyce, C. J., Valant, C., Christopoulos, A., & Thal, D. M. (2024) · Science Advances · doi:10.1126/sciadv.adp7040 · Cited by 16
Zandarashvili, L., Esadze, A., Kemme, C. A., Chattopadhyay, A., Nguyen, D., & Iwahara, J. (2016) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6b00019 · Cited by 15
Park, J., Al-Hilal, T. A., Jeong, J., Choi, J. U., & Byun, Y. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00230 · Cited by 15
In Vitro Kinetic Profiling of Hepatitis C Virus NS3 Protease Inhibitors by Progress Curve Analysis
Zhang, R., & Windsor, W. T. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-484-5_6 · Cited by 15
de Witte, W. E. A., Versfelt, J. W., Kuzikov, M., Rolland, S., Georgi, V., Gribbon, P. M., Gul, S., Huntjens, D. R. H., van der Graaf, P. H., Danhof, M., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14456 · Cited by 15
Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool
Chen, W., Ren, X., & Chang, C. A. (2018) · ChemMedChem · doi:10.1002/cmdc.201800559 · Cited by 15
Huang, S., Zhang, D., Hu, M. Y., Kevin, M., Qu, S., Pan, X., & Lu, L. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00567 · Cited by 16
Exploring Structure–Property Relationships of GAGs to Tailor ECM-Mimicking Hydrogels
Zimmermann, R., Werner, C., & Sterling, J. D. (2018) · Polymers · doi:10.3390/polym10121376 · Cited by 15
Metadata
- Authors
- Copeland, R. A., Pompliano, D. L., & Meek, T. D.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Copeland, Robert A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-08-04
- Volume
- 5
- Issue
- 9
- Pages
- 730-739
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2016408686
- Semantic Scholar
- 362824beb2008831aa65b4eb774e5c8703ff9c71
- Cited by
- 1,464
- References
- 46
- Citations by year
- 2026: 83 · 2025: 64 · 2024: 78 · 2023: 79 · 2022: 81 · 2021: 76 · 2020: 83 · 2019: 88 · 2018: 102 · 2017: 104 · 2016: 96 · 2015: 120 · 2014: 74 · 2013: 88 · 2012: 65
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
- Keywords
- drug-target residence time, lead optimization, drug selectivity, drug-target binding, binding affinity
- MeSH terms
- Binding, Competitive, Pharmaceutical Preparations, Humans, Kinetics, Ligands, Technology, Pharmaceutical, Drug Design, Drug Delivery Systems, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.